MX9204996A - Compuestos amino terciarios triazolil-substituidos y sus sales. - Google Patents

Compuestos amino terciarios triazolil-substituidos y sus sales.

Info

Publication number
MX9204996A
MX9204996A MX9204996A MX9204996A MX9204996A MX 9204996 A MX9204996 A MX 9204996A MX 9204996 A MX9204996 A MX 9204996A MX 9204996 A MX9204996 A MX 9204996A MX 9204996 A MX9204996 A MX 9204996A
Authority
MX
Mexico
Prior art keywords
triazolil
salts
substituted amino
tertiary compounds
amino tertiary
Prior art date
Application number
MX9204996A
Other languages
English (en)
Spanish (es)
Inventor
Minoru Okada
Eiji Kawaminami
Toru Yoden
Masafumi Kudo
Yasuo Isomura
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of MX9204996A publication Critical patent/MX9204996A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX9204996A 1991-09-02 1992-08-31 Compuestos amino terciarios triazolil-substituidos y sus sales. MX9204996A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24826891 1991-09-02
JP34401191 1991-12-02

Publications (1)

Publication Number Publication Date
MX9204996A true MX9204996A (es) 1993-08-01

Family

ID=26538684

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204996A MX9204996A (es) 1991-09-02 1992-08-31 Compuestos amino terciarios triazolil-substituidos y sus sales.

Country Status (20)

Country Link
US (1) US5674886A (enExample)
EP (1) EP0641785B1 (enExample)
KR (1) KR100204697B1 (enExample)
CN (1) CN1035817C (enExample)
AT (1) ATE186052T1 (enExample)
AU (1) AU665569B2 (enExample)
BG (1) BG61688B1 (enExample)
CA (1) CA2116773C (enExample)
DE (1) DE69230225T2 (enExample)
ES (1) ES2139605T3 (enExample)
FI (1) FI940988L (enExample)
HU (1) HU220863B1 (enExample)
MX (1) MX9204996A (enExample)
NO (1) NO305284B1 (enExample)
PT (1) PT100821B (enExample)
RO (1) RO114129B1 (enExample)
RU (1) RU2124010C1 (enExample)
TW (1) TW225526B (enExample)
UA (1) UA41295C2 (enExample)
WO (1) WO1993005027A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
RU2131422C1 (ru) * 1997-05-21 1999-06-10 Иван Антонович Мазур Бромид 1-пентил-4-(п-метоксибензилиденамино)-1,2,4-триазолия, проявляющий спазмолитическую активность
US7022702B2 (en) * 2000-04-07 2006-04-04 Qlt Inc. Antiproliferative 1,2,3-thiadiazole compounds
US6420400B1 (en) 2000-04-07 2002-07-16 Kinetek Pharmaceuticals, Inc. Antiproliferative 1,2,3-thiadiazole compounds
IL156584A0 (en) * 2000-12-22 2004-01-04 Ortho Mcneil Pharm Inc Substituted triazole diamine derivatives as kinase inhibitors
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
GB0127923D0 (en) 2001-11-21 2002-01-16 Sterix Ltd Compound
WO2003045925A1 (en) * 2001-11-21 2003-06-05 Sterix Limited 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのｎ−フェニル−３−シクロプロピルピラゾール−４−カルボニトリル
EP1431292A1 (en) * 2002-12-16 2004-06-23 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors
AU2011226950B9 (en) * 2003-12-15 2013-04-11 Laboratoire Theramex 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them
US8476455B2 (en) 2003-12-15 2013-07-02 Laboratoire Theramex 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
EP1544195A1 (en) * 2003-12-15 2005-06-22 Laboratoire Theramex 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them
GB0411562D0 (en) * 2004-05-24 2004-06-23 Sterix Ltd Compound
JP5777163B2 (ja) * 2009-07-03 2015-09-09 国立研究開発法人理化学研究所 Ｐｅｔ用標識化合物
GB0914767D0 (en) * 2009-08-24 2009-09-30 Sterix Ltd Compound
CN113387894B (zh) * 2021-06-22 2023-02-24 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 1-n-苯乙腈基氨基-三氮唑和嘧啶衍生物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2488891A1 (fr) * 1980-08-22 1982-02-26 Roussel Uclaf Nouveaux derives du 4h-1,2,4-triazole, leur procede de preparation et leur application comme medicament
DE3410700A1 (de) * 1984-03-23 1985-09-26 Basf Ag, 6700 Ludwigshafen 2,4,5-triphenyl-v-triazole und deren verwendung
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4661508A (en) * 1984-06-18 1987-04-28 Eli Lilly And Company Aromatase inhibiting α,α-diphenyl-4(5)imidazole-methanes or -ethanes
US4749713A (en) 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
CH677925A5 (enExample) * 1986-12-03 1991-07-15 Sandoz Ag
US5041458A (en) * 1987-03-20 1991-08-20 E. I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
EP0349580B1 (en) * 1987-03-20 1991-05-15 E.I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.

Also Published As

Publication number Publication date
FI940988A7 (fi) 1994-04-05
ES2139605T3 (es) 2000-02-16
BG61688B1 (bg) 1998-03-31
CA2116773C (en) 2002-12-10
FI940988A0 (fi) 1994-03-02
AU665569B2 (en) 1996-01-11
DE69230225T2 (de) 2000-05-31
ATE186052T1 (de) 1999-11-15
KR100204697B1 (ko) 1999-06-15
FI940988L (fi) 1994-04-05
RO114129B1 (ro) 1999-01-29
HU9400611D0 (en) 1994-09-28
CN1035817C (zh) 1997-09-10
EP0641785A4 (en) 1994-06-16
US5674886A (en) 1997-10-07
CN1069974A (zh) 1993-03-17
NO940686D0 (no) 1994-02-28
AU2487492A (en) 1993-04-05
PT100821B (pt) 1999-07-30
EP0641785A1 (en) 1995-03-08
PT100821A (pt) 1993-11-30
BG98618A (bg) 1995-03-31
EP0641785B1 (en) 1999-10-27
CA2116773A1 (en) 1993-03-18
DE69230225D1 (de) 1999-12-02
RU2124010C1 (ru) 1998-12-27
TW225526B (enExample) 1994-06-21
HU220863B1 (en) 2002-06-29
NO305284B1 (no) 1999-05-03
NO940686L (enExample) 1994-04-29
HUT67249A (en) 1995-03-28
WO1993005027A1 (fr) 1993-03-18
UA41295C2 (uk) 2001-09-17

Similar Documents

Publication Publication Date Title
MX9204996A (es) Compuestos amino terciarios triazolil-substituidos y sus sales.
UY23835A1 (es) Procedimiento para la preparacion de compuesto de acilo
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
ES2101261T3 (es) Uso de taxol para la fabricacion de un medicamento para el tratamiento del cancer.
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
DE50310516D1 (de) Fredericamycin-derivate
CY1105477T1 (el) Αναστολεις τρανσφepασης φαρνεσυλ πρωτεϊνης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου
ES2097341T3 (es) Indoles sustituidos como farmacos para el tratamiento del sida.
ES2092113T3 (es) Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno.
TR200003879T2 (tr) İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@
MX9303158A (es) Derivados de aminoquinolona substituidos con grupoarilo o con un grupo heterociclico aromatico; y agente anti-vih.
PL360262A1 (pl) Kompozycje polimerycznych micelli
MXPA05012573A (es) Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de cinasa.
ES2082959T3 (es) Procedimiento para desarrollar la sintesis de una droga contraceptiva y de control del ciclo menstrual que tiene propiedades anticinetosicas, oncostaticas y terapeuticas para el tratamiento de los tumores de mama y melanomas.
ES2131842T3 (es) Compuestos de triazol y su empleo como ligandos de dopamina-d3.
MX2023011715A (es) Compuestos de oxoisoindolina sustituidos con piridinilo.
BR112021025699A2 (pt) Anticorpos anti-mesotelina e imunoconjugados dos mesmos
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
TR200002969T2 (tr) Farmasötik bileşim.
BR0209645A (pt) Oxazolo- e furopirimidinas e seu uso como medicamentos
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
ES2163795T3 (es) Composicion farmaceutica contra los tumores e infecciones por papilomavirus.
ES2123511T3 (es) Derivados imidazopiridina, procedimiento de preparacion y aplicaciones.
MX9800248A (es) Uso de alcaloides de clase lamelar en metodos de tratamiento.
PT841912E (pt) 2-aminocarbonil-1,2-bis(metilsulfonil)-1-(substituido)-hidrazinas antitumor